Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Novel Oral Natural Extract for the Treatment of Senile Purpura

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Nexgen Dermatologics, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Nexgen Dermatologics, Inc.
ClinicalTrials.gov Identifier:
NCT01183910
First received: August 16, 2010
Last updated: June 6, 2011
Last verified: June 2011

August 16, 2010
June 6, 2011
November 2008
July 2011   (final data collection date for primary outcome measure)
IMPROVEMENT IN PATIENT'S SKIN APPEARANCE WITH SENILE PURPURA [ Time Frame: 6 WEEKS ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01183910 on ClinicalTrials.gov Archive Site
ADVERSE EFFECTS IN PATIENTS WITH SENILE PURPURA TAKING THIS MEDICATION [ Time Frame: 6 WEEKS ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
A Novel Oral Natural Extract for the Treatment of Senile Purpura
A Randomized, Double-Blind, Placebo-Controlled Study To Assess the Safety and Efficacy of a Novel Oral Natural Extract for the Treatment of Senile Purpura

A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator)
PURPURA
  • Dietary Supplement: Citrus Bioflavanoid Blend
    Pill Taken Twice a Day
  • Dietary Supplement: Calcium Carbonate
    Oral Tablet Taken Twice a Day
  • Placebo Comparator: Calcium carbonate placebo pill
    Placebo medication to treat the appearance of the skin in patients with senile purpura
    Intervention: Dietary Supplement: Calcium Carbonate
  • Active Comparator: Nutraceutical
    Patients take a novel, natural nutraceutical product to improve the appearance of the skin of patients with senile purpura
    Intervention: Dietary Supplement: Citrus Bioflavanoid Blend
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
75
August 2011
July 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with evidence of purpura on physical exam

Exclusion Criteria:

  • Preexisting condition that would not allow the patients to take oral calcium supplement
Both
40 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01183910
021775
Yes
GARY BERLIN, ESQUIRE, NEXGEN DERMATOLOGICS, INC.
Nexgen Dermatologics, Inc.
Not Provided
Principal Investigator: JOSHUA M BERLIN, MD STUDY PROTOCOL, INC
Nexgen Dermatologics, Inc.
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP